Active ingredientIndoramin HydrochlorideCat. No. P-I046-001CAS 38821-52-2Family · Pharmaceutical analytical standards
Indoramin
A selective alpha-1 adrenergic receptor antagonist, developed between the late 1960s and the early 1970s for its blood-pressure-lowering action and also used in benign prostatic hyperplasia. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?In its molecule an indole ring is joined, through a two-carbon chain, to a piperidine ring; it is usually synthesised starting from tryptophol.
Go to the active ingredient →Active ingredientIndoramin HydrochlorideCat. No. P-I046-001CAS 38821-52-2
Pharmacopoeial impurityIndoramin EP Impurity ACat. No. P-I046-002CAS 3389-21-7
Pharmacopoeial impurityIndoramin EP Impurity BCat. No. P-I046-003CAS 971-34-6
Isotopically labelled6-Hydroxy Indoramin-d5Cat. No. P-I046-004
Isotopically labelledIndoramine-d5Cat. No. P-I046-005
NitrosamineN1,N3 -Dinitroso IndoramineCat. No. P-I046-006
NitrosamineN3-Nitroso IndoramineCat. No. P-I046-008
Impurity6-Hydroxy IndoraminCat. No. P-I046-009CAS 79146-88-6
Active ingredientIndoramineCat. No. P-I046-010CAS 26844-12-2
ImpurityN-(4-Piperidyl)benzamideCat. No. P-I046-011CAS 33953-37-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.